• Find a Doctor
  • News
  • Events
  • Videos
  • Careers
  • Locations
  • Make a Gift
  • 212-263-4432
  • Follow us on Facebook. Opens in a new tab
  • Follow us on Twitter. Opens in a new tab
  • Follow us on Youtube. Opens in a new tab
  • Follow us on Instagram. Opens in a new tab
  • Follow us on LinkedIn. Opens in a new tab
Clinical Trials at NYU Medical Centre

Perlmutter Cancer Center

Clinical Trials & Research Studies

  • Clinical Trials
  • FAQs
  • Login
  • Perlmutter Cancer Center
  • Cancer Research Overview
Start Over
Search Filters
Please enter a keyword
Please choose location
Trial Filters
Clear Trial Filters
Gender

Female (1)

Trial Phase

Phase 1/2 (1)

Healthy Volunteers

No (1)

Age Group

Adult (18+) (1)

Displaying 1 (all) recruiting clinical trials.

Phase 1/2
Female
  • A Phase I/II study Evaluating the Dosing Safety Efficacy and Biological Activity of Intraperitoneal GEN-1 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) Administered in Combination with Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed with Advanced Epithelial Ovarian Fallopian Tube or Primary Peritoneal Cancer

    You are being asked to take part in this study because you have epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer and you ...
    Phase phase 5 icon interventional phase icon Interventional

 

  • «
  • ←
  • 1
  • →
  • »
  • NYU Langone Health
  • Policies & Disclaimers

Make a Gift ยป


Powered By Trialx iConnect logo